Dr. Clara Liu Chung Ming is a Research Officer at the Heart Research Institute under Prof. Julie McMullen, specializing in bioengineering advanced 3D in vitro models to study human heart pathophysiology and cancer therapy-induced cardiotoxicity. Her work includes developing a patient-personalised platform to identify biomarkers leading to cardiotoxicity and to validate cardioprotective drugs. She has also pioneered research on the "heart attack-in-a-Petri-dish" model and investigating drug-induced cardiotoxicity using patient-derived stem cells. Clara's research extends to studying the impact of SARS-CoV-2 on human heart pathophysiology and bioengineering models of pre-eclampsia-induced heart failure using stem cells from patient’s blood. Her contributions have been recognized with multiple awards, including the FEIT HDR Women in Engineering and IT Award (2021), ASBTE Rapid Fire Presentation Award (2022), NSW Education Waratah Scholarship (2022–2024), Royal Society NSW Scholarship (2022), ASM PhD Rising Star Award (2023), Dean’s Award (2024) and Chancellor’s Award (2024) for best thesis at University of Technology Sydney.